Home / Fact sheets / Finland / Cervical quantitative data
Country fact sheet: Finland (Index year: )
Age group | 20-24 | 25-29 | 30-34 | 35-39 | 40-44 | 45-49 | 50-54 | 55-59 | 60-64 | 65-69 | 70-74 | 75-79 | Age unknown | Total |
Interval | ||||||||||||||
Screening interval (months) | 0 | 0 | 60 | 60 | 60 | 60 | 60 | 60 | 60 | 0 | 0 | 0 | 0 | |
Population (personally invited) | ||||||||||||||
Target population | 0 | 0 | 167305 | 160340 | 160821 | 184591 | 185308 | 191717 | 198366 | 0 | 0 | 0 | 0 | 1 248 448 |
Annual target population | 0 | 0 | 33 461 | 32 068 | 32 164 | 36 918 | 37 061 | 38 343 | 39 673 | 0 | 0 | 0 | 0 | 249 688 |
Women invited | 0 | 0 | 33623 | 32902 | 29120 | 35680 | 36881 | 37325 | 39056 | 0 | 0 | 0 | 0 | 244 587 |
Invitation coverage (%) | 0.0 | 0.0 | 100.5 | 102.6 | 90.5 | 96.6 | 99.5 | 97.3 | 98.4 | 0.0 | 0.0 | 0.0 | 0.0 | 98.0 |
Examinations | ||||||||||||||
Women screened | 0 | 0 | 18 078 | 19 482 | 18 992 | 24 367 | 26 632 | 27 662 | 29 665 | 0 | 0 | 0 | 0 | 164 878 |
Examination coverage rate (%) | 0.0 | 0.0 | 53.8 | 59.2 | 65.2 | 68.3 | 72.2 | 74.1 | 76.0 | 0.0 | 0.0 | 0.0 | 0.0 | 67.4 |
Result (A subset of tests) | ||||||||||||||
Subset women screened | 0 | 0 | 18 996 | 20 604 | 20 451 | 26 299 | 28 527 | 29 036 | 30 569 | 0 | 0 | 0 | 0 | 174 482 |
Positive | 0 | 0 | 250 | 257 | 206 | 232 | 228 | 203 | 160 | 0 | 0 | 0 | 0 | 1 536 |
Negative | 0 | 0 | 18 734 | 20 336 | 20 236 | 26 061 | 28 296 | 28 826 | 30 399 | 0 | 0 | 0 | 0 | 172 888 |
Unknown | 0 | 0 | 12 | 11 | 9 | 6 | 3 | 7 | 10 | 0 | 0 | 0 | 0 | 58 |
Referral for further assessment (%) | 0.0 | 0.0 | 1.3 | 1.2 | 1.0 | 0.9 | 0.8 | 0.7 | 0.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.9 |
Further assessment (all positive) | ||||||||||||||
Done | 0 | 0 | 246 | 255 | 204 | 229 | 226 | 200 | 157 | 0 | 0 | 0 | 0 | 1 517 |
Not done | 0 | 0 | 4 | 2 | 2 | 3 | 2 | 3 | 3 | 0 | 0 | 0 | 0 | 19 |
Unknown | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Further assessment participation rate (%) | 0.0 | 0.0 | 98.4 | 99.2 | 99.0 | 98.7 | 99.1 | 98.5 | 98.1 | 0.0 | 0.0 | 0.0 | 0.0 | 98.8 |
Outcome (CIN 1, CIN 2 and CIN 3 separetely) | ||||||||||||||
No biopsy performed, no CIN nor ca detected | 0 | 0 | 97 | 105 | 94 | 137 | 152 | 151 | 114 | 0 | 0 | 0 | 0 | 850 |
No biopsy performed, treated on the basis of colpo diagnosis of CIN (see and treat) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Unsatisfactory histology | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Carcinoma | 0 | 0 | 4 | 2 | 1 | 2 | 0 | 4 | 2 | 0 | 0 | 0 | 0 | 15 |
CIN3 / Adenocarcinoma in situ (CGIN) | 0 | 0 | 65 | 56 | 41 | 21 | 21 | 12 | 12 | 0 | 0 | 0 | 0 | 228 |
CIN2 | 0 | 0 | 45 | 44 | 39 | 35 | 21 | 11 | 7 | 0 | 0 | 0 | 0 | 202 |
CIN1 | 0 | 0 | 32 | 38 | 23 | 24 | 24 | 16 | 15 | 0 | 0 | 0 | 0 | 172 |
Other histology | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Unknown | 0 | 0 | 3 | 10 | 6 | 10 | 8 | 6 | 7 | 0 | 0 | 0 | 0 | 50 |